// App-Quantinova.ai

P478 : Treatment with ferric maltol associated with improvements in quality of life for IBD patients with iron deficiency anaemia

Researchers

Presenter

  • C Schmidt

Principal Investigators

  • D Baumgart

  • B Bokemeyer

  • C Bning

  • S Howaldt

  • A Stallmach

  • C Singfield

  • G Tremblay

  • T Jones

Medical Centers

  • Klinikum Fulda AG, Medical Clinic II Gastroenterology and Metabolic Disease, Fulda, Germany

  • Jena University Hospital, Internal Medicine I, Jena, Germany,

  • Charité Medical School, Humboldt-University of Berlin, 10Department of Gastroenterology and Hepatology, Berlin, Germany

  • Gastroenterology Practice, Minden, Germany

  • Waldfriede Hospital, Internal Medicine Department, Berlin, Germany

  • HaFCED e.K., Research Institute for IBD, Hamburg, Germany

  • Shield Therapeutics, London, UK

  • Purple Squirrel Economics, LLC, New York, NY

Locations

  • Germany

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved